Fig. 12From: Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancerDrug sensitivity prediction in low- and high-risk groups. Box plots depicting more sensitive drugs in the high-risk group (A, B). Box plot illustrating more sensitive drugs in the low-risk group (C, D)Back to article page